Mesoporous Bioactive Glasses: Structure Characteristics, Drug/growth Factor Delivery and Bone Regeneration Application

Overview

Journal Interface Focus

Specialty Biology

Date 2013 Jun 7

PMID 23741607

Citations 78

Authors

Chengtie Wu

Jiang Chang

Affiliations

Soon will be listed here.

Abstract

The impact of bone diseases and trauma in the whole world has increased significantly in the past decades. Bioactive glasses are regarded as an important bone regeneration material owing to their generally excellent osteoconductivity and osteostimulativity. A new class of bioactive glass, referred to as mesoporous bioglass (MBG), was developed 7 years ago, which possess a highly ordered mesoporous channel structure and a highly specific surface area. The study of MBG for drug/growth factor delivery and bone tissue engineering has grown significantly in the past several years. In this article, we review the recent advances of MBG materials, including the preparation of different forms of MBG, composition-structure relationship, efficient drug/growth factor delivery and bone tissue engineering application. By summarizing our recent research, the interaction of MBG scaffolds with bone-forming cells, the effect of drug/growth factor delivery on proliferation and differentiation of tissue cells and the in vivo osteogenesis of MBG scaffolds are highlighted. The advantages and limitations of MBG for drug delivery and bone tissue engineering have been compared with microsize bioactive glasses and nanosize bioactive glasses. The future perspective of MBG is discussed for bone regeneration application by combining drug delivery with bone tissue engineering and investigating the in vivo osteogenesis mechanism in large animal models.

Citing Articles

Antimicrobial properties of bimetallic-containing mesoporous bioglass against .

Wong K, Li Y, Yang H, Chien C, Kao L, Lin T J Dent Sci. 2025; 20(1):510-521.

PMID: 39873063 PMC: 11762196. DOI: 10.1016/j.jds.2024.04.029.

Gelatin-Modified Bioactive Glass for Treatment of Dentin Hypersensitivity.

Tang M, Ge M, Zhang X, Zhang X, Wang Y, Yang Y Int J Mol Sci. 2024; 25(22).

PMID: 39595935 PMC: 11593888. DOI: 10.3390/ijms252211867.

Personalized bioceramic grafts for craniomaxillofacial bone regeneration.

de Carvalho A, Rahimnejad M, Oliveira R, Sikder P, Saavedra G, Bhaduri S Int J Oral Sci. 2024; 16(1):62.

PMID: 39482290 PMC: 11528123. DOI: 10.1038/s41368-024-00327-7.

3D printed polycaprolactone/gelatin/ordered mesoporous calcium magnesium silicate nanocomposite scaffold for bone tissue regeneration.

Mirzavandi Z, Poursamar S, Amiri F, Bigham A, Rafienia M J Mater Sci Mater Med. 2024; 35(1):58.

PMID: 39348082 PMC: 11442632. DOI: 10.1007/s10856-024-06828-5.

Mesoporous Bioactive Glass-Incorporated Injectable Strontium-Containing Calcium Phosphate Cement Enhanced Osteoconductivity in a Critical-Sized Metaphyseal Defect in Osteoporotic Rats.

Ray S, Thormann U, Kramer I, Sommer U, Budak M, Schumacher M Bioengineering (Basel). 2023; 10(10).

PMID: 37892933 PMC: 10604136. DOI: 10.3390/bioengineering10101203.

References

Wu X, Wei J, Lu X, Lv Y, Chen F, Zhang Y . Chemical characteristics and hemostatic performances of ordered mesoporous calcium-doped silica xerogels. Biomed Mater. 2010; 5(3):35006. DOI: 10.1088/1748-6041/5/3/035006. View

Wu C, Zhu Y, Chang J, Zhang Y, Xiao Y . Bioactive inorganic-materials/alginate composite microspheres with controllable drug-delivery ability. J Biomed Mater Res B Appl Biomater. 2010; 94(1):32-43. DOI: 10.1002/jbm.b.31621. View

Lopez-Noriega A, Arcos D, Vallet-Regi M . Functionalizing mesoporous bioglasses for long-term anti-osteoporotic drug delivery. Chemistry. 2010; 16(35):10879-86. DOI: 10.1002/chem.201000137. View

Lin H, Wang W, Hsiung P, Shyu S . Light-sensitive intelligent drug delivery systems of coumarin-modified mesoporous bioactive glass. Acta Biomater. 2010; 6(8):3256-63. DOI: 10.1016/j.actbio.2010.02.014. View

Jones J, Tsigkou O, Coates E, Stevens M, Polak J, Hench L . Extracellular matrix formation and mineralization on a phosphate-free porous bioactive glass scaffold using primary human osteoblast (HOB) cells. Biomaterials. 2006; 28(9):1653-63. DOI: 10.1016/j.biomaterials.2006.11.022. View

Vallet-Regi M, Balas F, Arcos D . Mesoporous materials for drug delivery. Angew Chem Int Ed Engl. 2007; 46(40):7548-58. DOI: 10.1002/anie.200604488. View

Wu C, Fan W, Chang J, Xiao Y . Mesoporous bioactive glass scaffolds for efficient delivery of vascular endothelial growth factor. J Biomater Appl. 2012; 28(3):367-74. DOI: 10.1177/0885328212453635. View

Wu C, Zhang Y, Zhu Y, Friis T, Xiao Y . Structure-property relationships of silk-modified mesoporous bioglass scaffolds. Biomaterials. 2010; 31(13):3429-38. DOI: 10.1016/j.biomaterials.2010.01.061. View

Laurencin D, Almora-Barrios N, de Leeuw N, Gervais C, Bonhomme C, Mauri F . Magnesium incorporation into hydroxyapatite. Biomaterials. 2010; 32(7):1826-37. DOI: 10.1016/j.biomaterials.2010.11.017. View

10.

Gough J, Notingher I, Hench L . Osteoblast attachment and mineralized nodule formation on rough and smooth 45S5 bioactive glass monoliths. J Biomed Mater Res A. 2004; 68(4):640-50. DOI: 10.1002/jbm.a.20075. View

11.

Alcaide M, Portoles P, Lopez-Noriega A, Arcos D, Vallet-Regi M, Portoles M . Interaction of an ordered mesoporous bioactive glass with osteoblasts, fibroblasts and lymphocytes, demonstrating its biocompatibility as a potential bone graft material. Acta Biomater. 2009; 6(3):892-9. DOI: 10.1016/j.actbio.2009.09.008. View

12.

Wu C, Luo Y, Cuniberti G, Xiao Y, Gelinsky M . Three-dimensional printing of hierarchical and tough mesoporous bioactive glass scaffolds with a controllable pore architecture, excellent mechanical strength and mineralization ability. Acta Biomater. 2011; 7(6):2644-50. DOI: 10.1016/j.actbio.2011.03.009. View

13.

Franco J, Hunger P, Launey M, Tomsia A, Saiz E . Direct write assembly of calcium phosphate scaffolds using a water-based hydrogel. Acta Biomater. 2009; 6(1):218-28. PMC: 2790014. DOI: 10.1016/j.actbio.2009.06.031. View

14.

Yun H, Kim S, Hyun Y, Heo S, Shin J . Hierarchically mesoporous-macroporous bioactive glasses scaffolds for bone tissue regeneration. J Biomed Mater Res B Appl Biomater. 2008; 87(2):374-80. DOI: 10.1002/jbm.b.31114. View

15.

Xia W, Chang J . Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system. J Control Release. 2005; 110(3):522-30. DOI: 10.1016/j.jconrel.2005.11.002. View

16.

Xynos I, Edgar A, Buttery L, Hench L, Polak J . Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun. 2000; 276(2):461-5. DOI: 10.1006/bbrc.2000.3503. View

17.

Zhong J, Greenspan D . Processing and properties of sol-gel bioactive glasses. J Biomed Mater Res. 2000; 53(6):694-701. DOI: 10.1002/1097-4636(2000)53:6<694::aid-jbm12>3.0.co;2-6. View

18.

Li X, Wang X, Zhang L, Chen H, Shi J . MBG/PLGA composite microspheres with prolonged drug release. J Biomed Mater Res B Appl Biomater. 2008; 89(1):148-54. DOI: 10.1002/jbm.b.31197. View

19.

Pietak A, Reid J, Stott M, Sayer M . Silicon substitution in the calcium phosphate bioceramics. Biomaterials. 2007; 28(28):4023-32. DOI: 10.1016/j.biomaterials.2007.05.003. View

20.

Hamadouche M, Meunier A, Greenspan D, Blanchat C, Zhong J, La Torre G . Long-term in vivo bioactivity and degradability of bulk sol-gel bioactive glasses. J Biomed Mater Res. 2001; 54(4):560-6. DOI: 10.1002/1097-4636(20010315)54:4<560::aid-jbm130>3.0.co;2-j. View